Pfizer Set to Raise £2.7 Billion From Haleon Stake Sale - Yahoo …
WEB4 hours ago · PFE. HLN. (Bloomberg) -- Pfizer Inc. plans to sell 540 million worth of shares in Haleon Plc, as it pares back its holding in the UK consumer health giant. Most Read from Bloomberg. A 7,000-Year ...
Pfizer to sell about $3.25 billion stake in Sensodyne-maker Haleon ...
WEB21 hours ago · Advertisement. Haleon separately said on Monday it had agreed to make an off-market purchase of about 230 million pounds ($308.18 million) worth of ordinary shares from Pfizer. In March, the U.S ...
Pfizer to offload about 6% stake in Sensodyne-maker Haleon, says …
WEB5 hours ago · Advertisement. Haleon separately said on Monday it had agreed to make an off-market purchase of about 230 million pounds ($308.18 million) worth of ordinary shares from Pfizer. In March, the U.S ...
Pfizer Intends to Sell Around 540 Million Ordinary Shares in Haleon ...
WEB4 hours ago · The sale is valued at roughly 2.12 billion pounds ($2.84 billion) based on Haleon's closing share price of 3.93 pounds on Monday. Pfizer will receive all net proceeds from the offering, it said.
Pfizer to Pare Back Haleon Stake With 540 Million Share Offering
WEB4 hours ago · Pfizer Inc.plans to sell 540 million worth of shares in Haleon Plc,as it pares back its holding in the UK consumer health giant. The US drug company said it will sell the stock in a statement ...
Pfizer to Offload About 5.9% Stake in UK's Haleon, Says ... - U.S. News
WEB21 hours ago · Reuters. FILE PHOTO: The company logo for Haleon and the trading info is displayed on a screen on the floor of the New York Stock Exchange (NYSE) in New York City, U.S., July 20, 2022.
Pfizer Set to Raise £2.7 Billion From Haleon Stake Sale (2)
WEBAshleigh Furlong. Pfizer Inc. is poised to raise about £2.7 billion ($3.6 billion) from the sale of Haleon Plc shares, as it further reduces its stake in the UK consumer health giant. The US company increased the number of shares to 640 million from 540 million after the sale had begun, according to terms of the deal seen by Bloomberg News ...
Press Releases - Haleon
WEBGender pay gap. Diversity, equity & inclusion. Human Rights. Being a responsible business is one of Haleon's four strategic priorities. See how we performed in 2022. ESG Reporting Hub. Investors. 100% Pure-play consumer health company with a clear purpose to deliver better everyday health with humanity.
GSK sells off remaining stake in Haleon - Financial Times
WEBMay 17, 2024 · GSK has sold its remaining stake in Haleon, the consumer healthcare company it spun off and listed in London in July 2022, raising £1.25bn and underscoring how pharmaceutical groups are ...
Haleon launches with purpose to deliver better everyday health …
WEBHaleon launches as an independent consumer health company, completing its GSK demerger. Trading commenced on the LSE with the CEO leading the ceremony. NYSE trading and a market-opening event are set for July 20, 2022.